FdaApplication
ANDA 220884
Identifiers
- fda_app_no: ANDA220884
Properties
| Property | Value |
|---|---|
| applicant_name | RUBICON RESEARCH |
| application_type | ANDA |
| approval_date | 2026-09-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; SPIRONOLACTONE | 25MG;25MG | TABLET;ORAL |
1 product